$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

$vrtx Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000087532018000009 Filed on February 15, 2018

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$651.6M	$578.2M	$544.1M
YoY Change	42.06%	39.73%	26.07%
Cost Of Revenue	$84.05M	$72.87M	$71.21M
YoY Change	40.92%	36.92%	61.27%
Gross Profit	$567.6M	$505.3M	$472.9M
YoY Change	42.23%	40.14%	22.06%
Gross Profit Margin	87.1%	87.4%	86.91%
Selling, General & Admin	$134.8M	$120.7M	$127.2M
YoY Change	22.64%	13.82%	13.97%
% of Gross Profit	23.75%	23.89%	26.91%
Research & Development	$306.7M	$454.9M	$289.5M
YoY Change	23.43%	67.03%	6.81%
% of Gross Profit	54.03%	90.04%	61.2%
Depreciation & Amortization	$16.40M	$15.30M	$14.80M
YoY Change	5.81%	5.52%	-1.33%
% of Gross Profit	2.89%	3.03%	3.13%
Operating Expenses	$441.5M	$575.7M	$416.7M
YoY Change	23.19%	52.12%	8.9%
Operating Profit	$125.7M	-$326.0M	$52.71M
YoY Change	217.2%	1641.03%	1471.94%
Interest Expense	-$12.55M	-$13.57M	-$14.66M
YoY Change	-38.61%	-32.6%	-27.24%
% of Operating Profit	-9.98%		-27.82%
Other Income/Expense, Net	-$748.0K	-$77.55M	-$2.537M
YoY Change	-167.69%	46338.92%	108.12%
Pretax Income	$112.4M	-$417.2M	$35.51M
YoY Change	453.74%	968.73%	-297.03%
Income Tax	$10.26M	-$125.9M	$4.337M
% Of Pretax Income	9.12%		12.21%
Net Earnings	$100.7M	-$103.0M	$18.00M
YoY Change	205.61%	165.06%	-127.89%
Net Earnings / Revenue	15.45%	-17.81%	3.31%
Basic Earnings Per Share	$0.40	-$0.41	$0.07
Diluted Earnings Per Share	$0.39	-$0.41	$0.07
COMMON SHARES
Basic Shares Outstanding	251.6M shares	250.3M shares	247.5M shares
Diluted Shares Outstanding	256.8M shares	250.3M shares	251.6M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.089B	$1.812B	$1.669B
YoY Change	45.57%	60.64%	55.84%
Cash & Equivalents	$1.665B	$1.385B	$1.223B
Short-Term Investments	$423.0M	$427.0M	$446.0M
Other Short-Term Assets	$75.74M	$154.0M	$172.0M
YoY Change	120.18%	29.41%	35.43%
Inventory	$111.8M	$98.19M	$92.26M
Prepaid Expenses	$62.48M
Receivables	$281.3M	$263.5M	$247.9M
Other Receivables	$29.00M	$0.00	$0.00
Total Short-Term Assets	$2.649B	$2.328B	$2.181B
YoY Change	44.63%	55.0%	49.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$789.4M	$760.0M	$740.1M
YoY Change	13.04%	10.52%	7.17%
Goodwill	$50.40M	$50.38M	$50.40M
YoY Change	0.03%	0.0%	0.03%
Intangibles
YoY Change
Long-Term Investments	$20.00M	$20.00M	$20.00M
YoY Change	0.0%	-62.26%	-39.39%
Other Assets	$27.40M	$10.54M	$9.943M
YoY Change	130.51%	5.4%	-29.99%
Total Long-Term Assets	$897.1M	$870.4M	$1.105B
YoY Change	-15.79%	-21.43%	0.93%
TOTAL ASSETS
Total Short-Term Assets	$2.649B	$2.328B	$2.181B
Total Long-Term Assets	$897.1M	$870.4M	$1.105B
Total Assets	$3.546B	$3.198B	$3.286B
YoY Change	22.41%	22.56%	28.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$73.99M	$77.14M	$75.94M
YoY Change	20.41%	51.51%	48.03%
Accrued Expenses	$444.0M	$378.6M	$345.1M
YoY Change	40.83%	29.64%	25.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$23.00M	$20.00M	$18.00M
YoY Change	21.05%	-93.67%	-92.47%
Total Short-Term Liabilities	$807.3M	$710.7M	$625.4M
YoY Change	1.86%	-1.67%	0.41%
LONG-TERM LIABILITIES
Long-Term Debt	$584.0M	$567.0M	$550.0M
YoY Change	12.09%	12.28%	-5.5%
Other Long-Term Liabilities	$27.77M	$26.03M	$25.22M
YoY Change	-3.22%	-14.73%	-17.71%
Total Long-Term Liabilities	$27.77M	$26.03M	$25.22M
YoY Change	-3.22%	-14.73%	-17.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$807.3M	$710.7M	$625.4M
Total Long-Term Liabilities	$27.77M	$26.03M	$25.22M
Total Liabilities	$1.504B	$1.395B	$1.418B
YoY Change	-3.52%	-0.44%	2.77%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.120B	-$5.220B	-$5.117B
YoY Change	-4.73%	-3.45%	-4.67%
Common Stock	$7.160B	$7.037B	$6.810B
YoY Change	10.0%	9.4%	7.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.029B	$1.791B	$1.671B
YoY Change
Total Liabilities & Shareholders Equity	$3.546B	$3.198B	$3.286B
YoY Change	22.41%	22.56%	28.9%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$100.7M	-$103.0M	$18.00M
YoY Change	205.61%	165.06%	-127.89%
Depreciation, Depletion And Amortization	$16.40M	$15.30M	$14.80M
YoY Change	5.81%	5.52%	-1.33%
Cash From Operating Activities	$227.5M	$170.1M	$181.6M
YoY Change	57.22%	158.9%	345.1%
INVESTING ACTIVITIES
Capital Expenditures	-$43.00M	-$187.9M	-$17.40M
YoY Change	190.54%	1251.8%	9.43%
Acquisitions
YoY Change
Other Investing Activities	$22.20M	-$37.30M	-$58.90M
YoY Change	-88.42%	-176.59%	40.57%
Cash From Investing Activities	-$20.80M	-$225.2M	-$76.30M
YoY Change	-111.76%	-747.13%	32.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	73.20M	152.7M	132.1M
YoY Change	-21.96%	1031.11%	520.19%
NET CHANGE
Cash From Operating Activities	227.5M	170.1M	181.6M
Cash From Investing Activities	-20.80M	-225.2M	-76.30M
Cash From Financing Activities	73.20M	152.7M	132.1M
Net Change In Cash	279.9M	97.60M	237.4M
YoY Change	-32.62%	-14.39%	5420.93%
FREE CASH FLOW
Cash From Operating Activities	$227.5M	$170.1M	$181.6M
Capital Expenditures	-$43.00M	-$187.9M	-$17.40M
Free Cash Flow	$270.5M	$358.0M	$199.0M
YoY Change	69.59%	349.75%	250.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0000875320
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	253891984	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	31800000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	VERTEX PHARMACEUTICALS INC / MA
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	61451000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	73994000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	200364000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	281343000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	315249000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	31400000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	35200000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	231025000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	237705000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	290736000	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2516000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	443961000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	52845000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	73044000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387798000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	432123000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2100000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7900000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-21000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21173000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11572000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6506795000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7157362000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	235112000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	241239000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	295642000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	24500000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1951000	USD
CY2016Q4	us-gaap	Assets Assets	2896787000	USD
CY2017Q4	us-gaap	Assets Assets	3546014000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	1831540000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	2648963000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	250612000	USD
CY2017Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	423254000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2017	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	19426000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	22531000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	34976000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	20496000	USD
CY2016Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	101300000	USD
CY2017Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	100900000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	45459000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	24004000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	1706000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	3676000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5434000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	58890000	USD
CY2015	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	361000	USD
CY2016	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	68000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	10252000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	387000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	2432000	USD
CY2017Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	43027000	USD
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	37900000	USD
CY2017Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	43400000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	625259000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	714768000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1183945000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1665412000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	89509000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	469177000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	481467000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	248300517	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	253253362	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	248300517	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	253253362	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2450000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2512000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-555427000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92703000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	230739000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-31847000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	28021000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-171849000	USD
CY2017	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	844000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	20276000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-587274000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-64682000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	20447000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	117151000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	49789000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	44154000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	53222000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	59646000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	206811000	USD
CY2017Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	46242000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	70535000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	72186000	USD
CY2017Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	83712000	USD
CY2017	us-gaap	Cost Of Goods Sold CostOfGoodsSold	272675000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	1499215000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	412410000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	428255000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	432510000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	419066000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	1692241000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	443876000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	491428000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	904208000	USD
CY2017Q4	us-gaap	Costs And Expenses CostsAndExpenses	525897000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	2365409000	USD
CY2016Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	25623000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-3821000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11559000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	831000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1794000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3576000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30083000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-191000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20160000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3629000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1836000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5025000	USD
CY2016Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	73416000	USD
CY2017Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	232401000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	497000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	18659000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-113805000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-355000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3359000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3222000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	298000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16856000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-127484000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6005000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5169000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6632000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1726000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	156000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1556000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-10457000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	31205000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	19593000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1981935000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1734542000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4705000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4250000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	250749000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	181600000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1232399000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1004404000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	27000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1417000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	367402000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	440429000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	110446000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	83196000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1731186000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1552942000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	133727000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	5518000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	134063000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	6341000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	7967000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	6401000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	134063000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	6341000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	169089000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	101019000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	73357000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	73357000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12800000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	11800000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12300000	USD
CY2015	us-gaap	Depreciation Depreciation	60000000	USD
CY2016	us-gaap	Depreciation Depreciation	60800000	USD
CY2017	us-gaap	Depreciation Depreciation	61400000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62343000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61398000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61397000	USD
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
CY2017	us-gaap	Derivative Term Of Contract DerivativeTermOfContract	P1M
CY2015	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	7361000	USD
CY2016Q1	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	860000	USD
CY2016Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	1098000	USD
CY2016Q3	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	855000	USD
CY2016Q4	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	836000	USD
CY2016	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	3649000	USD
CY2017Q1	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	746000	USD
CY2017Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	670000	USD
CY2017Q3	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	688000	USD
CY2017Q4	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	340000	USD
CY2017	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	2444000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.31
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.01
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.06
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.31
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.04
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2834000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4666000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	5802000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	86387000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	113026000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4087000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3607000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4906000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6800000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4000000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	5500000	USD
CY2017Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear	6000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-272326000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-147860000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	330340000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-285474000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	80494000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-346029000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-557800000	USD
CY2015	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2016	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-76644000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	50400000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	50384000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	50384000	USD
CY2015	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2016	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2017Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2017Q2	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2017Q3	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	255340000	USD
CY2017Q4	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	255340000	USD
CY2015	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2016	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2017	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-30617000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18021000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39034000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	20306000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-67366000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	253533000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35506000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-417170000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	112442000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-15689000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30381000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5485000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18130000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	503000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7453000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16665000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3985000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4337000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-125903000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10257000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-107324000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	226169000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14837000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-584917000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1224000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	12836000	USD
CY2017	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	575192000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	47402000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	21346000	USD
CY2017	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	77801000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-195230000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23578000	USD
CY2017	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5491000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	5817000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	24749000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	21825000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	951000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	4162000	USD
CY2017	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-21453000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1608000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3482000	USD
CY2017	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	248000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3800000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3621000	USD
CY2017	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4742000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	55696000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	47773000	USD
CY2017	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	49088000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1806000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2579000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6414000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1709000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11745000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8753000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	110098000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39095000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	71759000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	102746000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	88649000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	246217000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-19242000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13372000	USD
CY2017	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5913000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23146000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16450000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44984000	USD
CY2015	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	3283000	USD
CY2016	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	16961000	USD
CY2017	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-120513000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4009000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2631000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	111063000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-11685000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-31148000	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	15329000	USD
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-84206000	USD
CY2016Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20698000	USD
CY2016Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20155000	USD
CY2016Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20140000	USD
CY2016Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20439000	USD
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-81432000	USD
CY2017Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-16765000	USD
CY2017Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-14664000	USD
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-13574000	USD
CY2017Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-12547000	USD
CY2017	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-57550000	USD
CY2015	us-gaap	Interest Paid InterestPaid	85613000	USD
CY2016	us-gaap	Interest Paid InterestPaid	83656000	USD
CY2017	us-gaap	Interest Paid InterestPaid	68696000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14584000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16669000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	77604000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	111830000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6348000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20924000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	56672000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	74237000	USD
CY2015	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	15292000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18100000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	19100000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	19200000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1558596000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	1503708000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2896787000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3546014000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	792537000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	807260000	USD
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	300000000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	181609000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	13727000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	188919000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	133271000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	68404000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	268856000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	104469000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-437681000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-365432000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	236103000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	844942000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-556334000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-41631000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-64525000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-38841000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	32945000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-112052000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	247756000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	17996000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-102952000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	100684000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	263484000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-31847000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5529000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28374000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-696000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5186000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28021000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1792000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13173000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-188315000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1501000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-171849000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-556334000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-112052000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	263191000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-556334000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-112052000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	263196000	USD
CY2017Q4	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	6500000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	14238000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	40855000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	164317000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	698362000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	789437000	USD
CY2015	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2016	us-gaap	Notes Issued1 NotesIssued1	225000000	USD
CY2017	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-466879000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14330000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3353000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18727000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	39640000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	9936000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	270842000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	52707000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-326043000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	125737000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	123243000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1109960000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	84451000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	93258000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	93879000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	95672000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	92915000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	649785000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26728000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	39561000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	34400000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	74253000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11885000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7783000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	5633000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	28996000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-35390000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1109000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5782000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-13169000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	907000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19349000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-32745000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1767000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	7736000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-26530000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-3900000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	3400000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	249000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	17395000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2804000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6715000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4411000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	6954000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-3800000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-2700000	USD
CY2016Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	284340000	USD
CY2017Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	29000000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10943000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	27029000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	28699000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26048000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9532000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6140000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1219000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-167000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1105000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4130000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-544000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2537000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-77553000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-748000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-81382000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	21929000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-22022000	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-436000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3103000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	633041000	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	616625000	USD
CY2017	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	532581000	USD
CY2015	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
CY2016	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
CY2017	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	160000000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	80000000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2015	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	30000000	USD
CY2016	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	20000000	USD
CY2017	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45302000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56563000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	99421000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71253000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	165635000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	36134000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62475000	USD
CY2015	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0	USD
CY2016	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0	USD
CY2017	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	27182000	USD
CY2015	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	185592000	USD
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	68230000	USD
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	344840000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	300000000	USD
CY2015	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	23662000	USD
CY2016	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	11208000	USD
CY2017	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	7484000	USD
CY2015	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	74965000	USD
CY2017	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1067443000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	757562000	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	369214000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	165600000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	48500000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	323300000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-588181000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-36102000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-36151000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-39537000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	27759000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-84031000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	249548000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	31169000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-291267000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	102185000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	91635000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1086160000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1221560000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	698362000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	789437000	USD
CY2015	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	4726000	USD
CY2016	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	9647000	USD
CY2017	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	-2645000	USD
CY2015	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	300000000	USD
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	19954000	USD
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	17597000	USD
CY2017	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	18795000	USD
CY2015	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	75000000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	995922000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	255860000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	271008000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	272370000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	248452000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1047690000	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	273563000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	289451000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	454947000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	306664000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1324625000	USD
CY2015	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2016	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2017	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	160000000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	47762000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1489000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	2206000	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	687000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	343000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	8000	USD
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges	224000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	1262000	USD
CY2017Q1	us-gaap	Restructuring Charges RestructuringCharges	9999000	USD
CY2017Q2	us-gaap	Restructuring Charges RestructuringCharges	3523000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	337000	USD
CY2017Q4	us-gaap	Restructuring Charges RestructuringCharges	387000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	14246000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	6047000	USD
CY2017Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2175000	USD
CY2016Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	1907000	USD
CY2017Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	0	USD
CY2015	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-30492000	USD
CY2016	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-7426000	USD
CY2017	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-5987000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5373836000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5119723000	USD
CY2015	us-gaap	Revenues Revenues	1032336000	USD
CY2016Q1	us-gaap	Revenues Revenues	398080000	USD
CY2016Q2	us-gaap	Revenues Revenues	431608000	USD
CY2016Q3	us-gaap	Revenues Revenues	413783000	USD
CY2016Q4	us-gaap	Revenues Revenues	458706000	USD
CY2016	us-gaap	Revenues Revenues	1702177000	USD
CY2017Q1	us-gaap	Revenues Revenues	714718000	USD
CY2017Q2	us-gaap	Revenues Revenues	544135000	USD
CY2017Q3	us-gaap	Revenues Revenues	578165000	USD
CY2017Q4	us-gaap	Revenues Revenues	651634000	USD
CY2017	us-gaap	Revenues Revenues	2488652000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	23959000	USD
CY2016Q1	us-gaap	Royalty Revenue RoyaltyRevenue	3596000	USD
CY2016Q2	us-gaap	Royalty Revenue RoyaltyRevenue	5282000	USD
CY2016Q3	us-gaap	Royalty Revenue RoyaltyRevenue	3835000	USD
CY2016Q4	us-gaap	Royalty Revenue RoyaltyRevenue	3887000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	16600000	USD
CY2017Q1	us-gaap	Royalty Revenue RoyaltyRevenue	1551000	USD
CY2017Q2	us-gaap	Royalty Revenue RoyaltyRevenue	2861000	USD
CY2017Q3	us-gaap	Royalty Revenue RoyaltyRevenue	2231000	USD
CY2017Q4	us-gaap	Royalty Revenue RoyaltyRevenue	1345000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	7988000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1000324000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	394410000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	425651000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	409689000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	453882000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1683632000	USD
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	480622000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	513988000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	549642000	USD
CY2017Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	621228000	USD
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2165480000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	376575000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	105214000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111652000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106055000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109908000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	432829000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	113326000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	127249000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	120710000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	134794000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	496079000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	231025000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	237705000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	290736000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	11427114	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5313000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	80.14
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	252900000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	48600000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	302800000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	62000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	611000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2359000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	585293000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12642000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9767000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	81.41
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	91.57
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	70.90
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	105.24
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	99.53
CY2017	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	108.43
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	5313000	shares
CY2017Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	9767000	shares
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	231025000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	237705000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	290736000	USD
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	375472000	USD
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M12D
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	80.14
CY2017Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	91.57
CY2017	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y11M12D
CY2017	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4561000	shares
CY2015	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	185290000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	68006000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	345673000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1156582000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	2028579000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1096183000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1093628000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1338191000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2042306000	USD
CY2015	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	0	USD
CY2016	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	0	USD
CY2017	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	288000	USD
CY2015	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2016	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2017	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	293000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	400000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3800000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	306400000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	14800000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-178200000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-20852000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-104000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-9638000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	36023000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	49296000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	89201000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	122683000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	241312000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	243831000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244482000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244920000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247757000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244685000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248700000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	251635000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	250268000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	256804000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253225000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	241312000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243831000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244482000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244920000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245454000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244685000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	246024000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	247521000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	250268000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	251557000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	248858000	shares
CY2017	vrtx	Accounts Receivable Discount Period AccountsReceivableDiscountPeriod	P30D
CY2016Q4	vrtx	Accrued Research Development And Commercial Contract Costs AccruedResearchDevelopmentAndCommercialContractCosts	62756000	USD
CY2017Q4	vrtx	Accrued Research Development And Commercial Contract Costs AccruedResearchDevelopmentAndCommercialContractCosts	98411000	USD
CY2017	vrtx	Additional Milestone Payments AdditionalMilestonePayments	0	USD
CY2016Q4	vrtx	Cash Cash Equivalents And Available For Sale Securities Fair Value CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue	1434557000	USD
CY2017Q4	vrtx	Cash Cash Equivalents And Available For Sale Securities Fair Value CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue	2088666000	USD
CY2017Q4	vrtx	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	2100000000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Available For Sale Securities Amortized Cost CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost	1413220000	USD
CY2017Q4	vrtx	Cash Cash Equivalents Available For Sale Securities Amortized Cost CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost	2057652000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain	21422000	USD
CY2017Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain	31608000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross	85000	USD
CY2017Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross	594000	USD
CY2016Q4	vrtx	Collaborative Accounts Receivable Current CollaborativeAccountsReceivableCurrent	719000	USD
CY2017Q4	vrtx	Collaborative Accounts Receivable Current CollaborativeAccountsReceivableCurrent	28907000	USD
CY2015	vrtx	Collaborative Revenues CollaborativeRevenues	8053000	USD
CY2016Q1	vrtx	Collaborative Revenues CollaborativeRevenues	74000	USD
CY2016Q2	vrtx	Collaborative Revenues CollaborativeRevenues	675000	USD
CY2016Q3	vrtx	Collaborative Revenues CollaborativeRevenues	259000	USD
CY2016Q4	vrtx	Collaborative Revenues CollaborativeRevenues	937000	USD
CY2016	vrtx	Collaborative Revenues CollaborativeRevenues	1945000	USD
CY2017Q1	vrtx	Collaborative Revenues CollaborativeRevenues	232545000	USD
CY2017Q2	vrtx	Collaborative Revenues CollaborativeRevenues	27286000	USD
CY2017Q3	vrtx	Collaborative Revenues CollaborativeRevenues	26292000	USD
CY2017Q4	vrtx	Collaborative Revenues CollaborativeRevenues	29061000	USD
CY2017	vrtx	Collaborative Revenues CollaborativeRevenues	315184000	USD
CY2017	vrtx	Common Stock Votes Per Each Share CommonStockVotesPerEachShare	1	vote
CY2016Q4	vrtx	Construction Financing Obligation Noncurrent ConstructionFinancingObligationNoncurrent	486359000	USD
CY2017Q4	vrtx	Construction Financing Obligation Noncurrent ConstructionFinancingObligationNoncurrent	563406000	USD
CY2016Q4	vrtx	Contingent Liabilities ContingentLiabilities	0	USD
CY2017Q4	vrtx	Contingent Liabilities ContingentLiabilities	0	USD
CY2017Q4	vrtx	Deferred Revenue Royalty Purchase Agreement DeferredRevenueRoyaltyPurchaseAgreement	6900000	USD
CY2016Q4	vrtx	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	23078000	USD
CY2017Q4	vrtx	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	17808000	USD
CY2016Q4	vrtx	Deferred Tax Assets Intangibles DeferredTaxAssetsIntangibles	34938000	USD
CY2017Q4	vrtx	Deferred Tax Assets Intangibles DeferredTaxAssetsIntangibles	54091000	USD
CY2016Q4	vrtx	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	177735000	USD
CY2017Q4	vrtx	Deferred Tax Assets Lease Obligation DeferredTaxAssetsLeaseObligation	109354000	USD
CY2017Q4	vrtx	Defined Contribution Plan Number Of Shares Available For Grant DefinedContributionPlanNumberOfSharesAvailableForGrant	754744	shares
CY2016Q4	vrtx	Due To Collaborative Arrangement Counterparty DueToCollaborativeArrangementCounterparty	73423000	USD
CY2017Q4	vrtx	Due To Collaborative Arrangement Counterparty DueToCollaborativeArrangementCounterparty	78431000	USD
CY2015	vrtx	Effective Income Tax Rate Reconciliation Deconsolidation Of Variable Interest Entity Amount EffectiveIncomeTaxRateReconciliationDeconsolidationOfVariableInterestEntityAmount	0	USD
CY2016	vrtx	Effective Income Tax Rate Reconciliation Deconsolidation Of Variable Interest Entity Amount EffectiveIncomeTaxRateReconciliationDeconsolidationOfVariableInterestEntityAmount	0	USD
CY2017	vrtx	Effective Income Tax Rate Reconciliation Deconsolidation Of Variable Interest Entity Amount EffectiveIncomeTaxRateReconciliationDeconsolidationOfVariableInterestEntityAmount	126183000	USD
CY2015	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	0	USD
CY2016	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	9947000	USD
CY2017	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	0	USD
CY2015	vrtx	Incremental Common Shares Attributableto Dilutive Effect Other IncrementalCommonSharesAttributabletoDilutiveEffectOther	0	shares
CY2016	vrtx	Incremental Common Shares Attributableto Dilutive Effect Other IncrementalCommonSharesAttributabletoDilutiveEffectOther	0	shares
CY2017	vrtx	Incremental Common Shares Attributableto Dilutive Effect Other IncrementalCommonSharesAttributabletoDilutiveEffectOther	28000	shares
CY2017Q4	vrtx	Indemnification Claims IndemnificationClaims	0	USD
CY2016Q4	vrtx	Line Of Credit Facility Additional Borrowing Capacity LineOfCreditFacilityAdditionalBorrowingCapacity	300000000.0	USD
CY2017	vrtx	Maximum Defined Contribution Plan Employee Contribution Percentage Of Compensation MaximumDefinedContributionPlanEmployeeContributionPercentageOfCompensation	0.6
CY2017	vrtx	Noncontrolling Interest Increase From Deconsolidation Variable Interest Entity NoncontrollingInterestIncreaseFromDeconsolidationVariableInterestEntity	3910000	USD
CY2015	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	381000	USD
CY2016	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	432000	USD
CY2017	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	541000	USD
CY2015	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	0	USD
CY2016	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	13075000	USD
CY2017	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	0	USD
CY2017	vrtx	Percentageofemployeeseligibleforaccelerationofequityawards Percentageofemployeeseligibleforaccelerationofequityawards	0.05
CY2017	vrtx	Prior Period Adjustmentas Total Percentof Net Product Revenues PriorPeriodAdjustmentasTotalPercentofNetProductRevenues	0.005
CY2015	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	0	USD
CY2016	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	75000000	USD
CY2017	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	12500000	USD
CY2008	vrtx	Proceeds From Sale Of Royalty Rights ProceedsFromSaleOfRoyaltyRights	160000000	USD
CY2016Q4	vrtx	Product Sales Accrued Liabilities ProductSalesAccruedLiabilities	86533000	USD
CY2017Q4	vrtx	Product Sales Accrued Liabilities ProductSalesAccruedLiabilities	119919000	USD
CY2015	vrtx	Repaymentsof Collaborative Funding RepaymentsofCollaborativeFunding	0	USD
CY2016	vrtx	Repaymentsof Collaborative Funding RepaymentsofCollaborativeFunding	0	USD
CY2017	vrtx	Repaymentsof Collaborative Funding RepaymentsofCollaborativeFunding	4266000	USD
CY2016Q2	vrtx	Researchand Development Expenses Earlystage Research Assets ResearchandDevelopmentExpensesEarlystageResearchAssets	10000000	USD
CY2017Q4	vrtx	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOutstandingNumber	13491491	shares
CY2015	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	81205000	USD
CY2016	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	163922000	USD
CY2017	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	222521000	USD
CY2015	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	47080000	USD
CY2016	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	123913000	USD
CY2017	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	179401000	USD
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, the fair value of intangible assets, goodwill, noncontrolling interest, the consolidation and deconsolidation of VIEs, leases, the fair value of cash flow hedges, deferred tax asset valuation allowances and the provision for or benefit from income taxes. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div></div>

Files In Submission

Name	View Source	Status
0000875320-18-000009-index-headers.html	Edgar Link	pending
0000875320-18-000009-index.html	Edgar Link	pending
0000875320-18-000009.txt	Edgar Link	pending
0000875320-18-000009-xbrl.zip	Edgar Link	pending
a10k2017exhibit41.htm	Edgar Link	pending
a10k_2017-exhibit1046.htm	Edgar Link	pending
a10k_2017-exhibit1047.htm	Edgar Link	pending
a10k_2017-exhibit107.htm	Edgar Link	pending
a10k_2017-exhibit211.htm	Edgar Link	pending
a10k_2017-exhibit231.htm	Edgar Link	pending
a10k_2017-exhibit311.htm	Edgar Link	pending
a10k_2017-exhibit312.htm	Edgar Link	pending
a10k_2017-exhibit321.htm	Edgar Link	pending
a201710k-main.htm	Edgar Link	pending
exhibit41001.jpg	Edgar Link	pending
exhibit41002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
linegrapha02.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrtx-20171231.xml	Edgar Link	completed
vrtx-20171231.xsd	Edgar Link	pending
vrtx-20171231_cal.xml	Edgar Link	unprocessable
vrtx-20171231_def.xml	Edgar Link	unprocessable
vrtx-20171231_lab.xml	Edgar Link	unprocessable
vrtx-20171231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2017 Q4 Form 10-K Financial Statement

#000087532018000009 Filed on February 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2017 Q4 Form 10-K Financial Statement

#000087532018000009 Filed on February 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx